Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132364) titled 'Randomized, Double-Blind, Placebo-Controlled Clinical Study of Akkermansia on Fat Reduction, Metabolic Improvement, and Safety in Obese Patients' on Sept. 14.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Nanchang Reproductive Hospital
Condition:
obesity
Intervention:
Placebo group:placebo
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Placebo group:50;AKK group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341264
Published by HT Digital Content Services with...